-
1
-
-
65249135896
-
A placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy
-
Dalakas MC, Rakocevic G, Salajegheh M, et al. A placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol 2009;65:286-93.
-
(2009)
Ann Neurol
, vol.65
, pp. 286-293
-
-
Dalakas, M.C.1
Rakocevic, G.2
Salajegheh, M.3
-
2
-
-
34250186792
-
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M
-
DOI 10.1111/j.1529-8027.2007.00129.x
-
Benedetti L, Briani C, Grandis M, et al. Predictors of response to rituximab in patients with neuropathy and anti-MAG IgM. J Peripher Nerv Syst 2007;12:102-7. (Pubitemid 46906332)
-
(2007)
Journal of the Peripheral Nervous System
, vol.12
, Issue.2
, pp. 102-107
-
-
Benedetti, L.1
Briani, C.2
Grandis, M.3
Vigo, T.4
Gobbi, M.5
Ghiglione, E.6
Carpo, M.7
Cocito, D.8
Caporale, C.M.9
Sormani, M.P.10
Mancardi, G.L.11
Nobile-Orazio, E.12
Schenone, A.13
-
3
-
-
58149262036
-
Long-term effect of rituximab in anti-MAG polyneuropathy
-
Benedetti L, Briani C, Franciotta D, et al. Long-term effect of rituximab in anti-MAG polyneuropathy. Neurology 2008;71:1742-4.
-
(2008)
Neurology
, vol.71
, pp. 1742-1744
-
-
Benedetti, L.1
Briani, C.2
Franciotta, D.3
-
4
-
-
0035860559
-
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway
-
DOI 10.1126/science.1061964
-
Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001;293:2111-14. (Pubitemid 32848063)
-
(2001)
Science
, vol.293
, Issue.5537
, pp. 2111-2114
-
-
Schiemann, B.1
Gommerman, J.L.2
Vora, K.3
Cachero, T.G.4
Shutga-Morskaya, S.5
Dobles, M.6
Frew, E.7
Scott, M.L.8
-
5
-
-
28344452325
-
The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome
-
DOI 10.1111/j.1365-3083.2005.01688.x
-
Szodoray P, Jonsson R. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome. Scand J Immunol 2005;62:421-8. (Pubitemid 41719317)
-
(2005)
Scandinavian Journal of Immunology
, vol.62
, Issue.5
, pp. 421-428
-
-
Szodoray, P.1
Jonsson, R.2
-
6
-
-
0033428703
-
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
-
DOI 10.1084/jem.190.11.1697
-
Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999;190:1697-710. (Pubitemid 30002351)
-
(1999)
Journal of Experimental Medicine
, vol.190
, Issue.11
, pp. 1697-1710
-
-
Mackay, F.1
Woodcock, S.A.2
Lawton, P.3
Ambrose, C.4
Baetscher, M.5
Schneider, P.6
Tschopp, J.7
Browning, J.L.8
-
7
-
-
54049122104
-
B cells as therapeutic targets in autoimmune neurological disorders
-
Dalakas MC. B cells as therapeutic targets in autoimmune neurological disorders. Nat Clin Pract Neurol 2008;4:557-67.
-
(2008)
Nat Clin Pract Neurol
, vol.4
, pp. 557-567
-
-
Dalakas, M.C.1
-
8
-
-
0026050521
-
Interobserver agreement in the assessment of muscle strenght and functional abilities in Guillain-Barré syndrome
-
Kleyweg RP, van der Mechè FGA, Schmitz PIM. Interobserver agreement in the assessment of muscle strenght and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991;14:1103-9.
-
(1991)
Muscle Nerve
, vol.14
, pp. 1103-1109
-
-
Kleyweg, R.P.1
Van Der Mechè, F.G.A.2
Schmitz, P.I.M.3
-
9
-
-
0034899193
-
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy
-
DOI 10.1002/ana.1088
-
Hughes R, Bensa S, Willison H, et al Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Randomized controlled trial of intravenous immunoglobulin versus oral prednilosone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201. (Pubitemid 32738144)
-
(2001)
Annals of Neurology
, vol.50
, Issue.2
, pp. 195-201
-
-
Hughes, R.1
MedSci, F.2
Bensa, S.3
Willison, H.4
Van Bergh, P.D.5
Comi, G.6
Illa, I.7
Nobile-Orazio, E.8
Van Doorn, P.9
Dalakas, M.10
Bojar, M.11
Swan, A.12
-
10
-
-
0034701011
-
Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies
-
Merkies I, Schmitz P, Van Der Mechè F, et al. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) group. Neurology 2000;54:943-9. (Pubitemid 30111356)
-
(2000)
Neurology
, vol.54
, Issue.4
, pp. 943-949
-
-
Merkies, I.S.J.1
Schmitz, P.I.M.2
Van Der, M.F.G.A.3
Van Doorn, P.A.4
-
11
-
-
49349099119
-
Serum BAFF predicts prognosis better than April in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy
-
Kim SJ, Lee SJ, Choi IY, et al. Serum BAFF predicts prognosis better than April in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy. Eur J Haematol 2008;81:177-84.
-
(2008)
Eur J Haematol
, vol.81
, pp. 177-184
-
-
Kim, S.J.1
Lee, S.J.2
Choi, I.Y.3
-
12
-
-
85056044235
-
Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma
-
Quartuccio L, Fabris M, Moretti M, et al. Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma. Open Rheumatol J 2008;2:38-43.
-
(2008)
Open Rheumatol J
, vol.2
, pp. 38-43
-
-
Quartuccio, L.1
Fabris, M.2
Moretti, M.3
-
13
-
-
44949245117
-
Inhibition of B cell functions
-
Dalakas MC. Inhibition of B cell functions. Neurology 2008;70:2252-60.
-
(2008)
Neurology
, vol.70
, pp. 2252-2260
-
-
Dalakas, M.C.1
-
14
-
-
0041571732
-
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
-
DOI 10.1002/art.11181
-
Cambridge G, Leandro MJ, Edwards JC, et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 2003;48:2146-54. (Pubitemid 36959194)
-
(2003)
Arthritis and Rheumatism
, vol.48
, Issue.8
, pp. 2146-2154
-
-
Cambridge, G.1
Leandro, M.J.2
Edwards, J.C.W.3
Ehrenstein, M.R.4
Salden, M.5
Bodman-Smith, M.6
Webster, A.D.B.7
|